Production (Stage)
Ondine Biomedical Inc.
OBIMF
$0.14
$0.00392.87%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.05M | -4.16M | -2.84M | -2.88M | -2.39M |
| Total Depreciation and Amortization | 100.40K | 103.00K | 103.80K | 105.30K | 103.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 269.70K | 276.80K | 137.00K | 139.10K | -16.90K |
| Change in Net Operating Assets | 676.50K | 694.30K | 6.90K | 7.00K | 292.90K |
| Cash from Operations | -3.00M | -3.08M | -2.59M | -2.63M | -2.01M |
| Capital Expenditure | 0.00 | 0.00 | -3.70K | -3.70K | -1.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -3.70K | -3.70K | -1.10K |
| Total Debt Issued | 826.00K | 826.00K | -- | -- | -- |
| Total Debt Repaid | -370.00K | -370.00K | -112.00K | -112.00K | -108.00K |
| Issuance of Common Stock | 8.46M | 8.46M | 3.03M | 3.03M | 2.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -690.50K | -690.50K | -275.00K | -275.00K | -350.00K |
| Cash from Financing | 5.88M | 6.03M | 1.93M | 1.96M | 1.47M |
| Foreign Exchange rate Adjustments | 182.20K | 187.00K | 15.00K | 15.20K | 14.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.06M | 3.14M | -646.00K | -655.70K | -532.20K |